Eclampsia
37
7
7
19
Key Insights
Highlights
Success Rate
95% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
2.7%
1 terminated out of 37 trials
95.0%
+8.5% vs benchmark
19%
7 trials in Phase 3/4
11%
2 of 19 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 19 completed trials
Clinical Trials (37)
PIERS and BIS, sFIT:PIGF, Adrenomedullin
Treatment With Aspirin After Preeclampsia: TAP Trial
Optimal Blood Pressure Treatment Thresholds Postpartum
Comparing Intravenous and Intramuscular Magnesium Sulphate for Preventing Seizure Recurrence in Women With Eclampsia
Free DNA and Nucleosome Concentrations in Pathological Pregnancies
Eliminating Severe Maternal Morbidity With Heart Health Doulas Trial
Pilot Project Renal and Cardiovascular Tertiary Prevention in Preeclampsia
Mobile Health Interventions to Prevent Heart Disease After Hypertensive Disorders of Pregnancy
Point-of-care Ultrasound Abnormalities in Eclampsia
The Preeclampsia Registry
Pulmonary Edema Resolution in Severe Preeclampsia and Eclampsia
An mHealth Strategy to Reduce Pre-Eclampsia and Infant Death in Tanzania
Comparison of Loading Dose Magnesium Sulphate With Prichard Regimen in the Management of Severe Preeclampsia and Eclampsia.
Effect of Acetaminophen on Postpartum Blood Pressure Control in Preeclampsia With Severe Features
Virtual Cardiac Wellness Program Following Hypertensive Disorders of Pregnancy
Investigation of Genetic Disease Marker Associated With Spontaneous Haemorrhagic Stroke Complicating Severe Pre-eclampsia in Pregnancy
Evaluation of the Serum Markers sFLt1 and PlGF for the Prediction of the Complications of the Placental Vascular Pathologies in the 3rd Quarter of the Pregnancy.
Prevention of Pre-eclampsia Using Metformin: a Randomized Control Trial
Microcirculatory and Tissue and Cerebral Oxygenation in Preeclampsia and Normal Pregnancy: An Observation Study
The Clinical and Prognostic Features of PRES